GLA-SE-adjuvanted leishmaniasis vaccine (Infectious Disease Research Institute)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameGLA-SE-adjuvanted leishmaniasis vaccine (Infectious Disease Research Institute)

Drug Alias NameGLA-SE-adjuvanted leishmaniasis vaccine (IDRI)LEISH-F3/GLA-SE adjuvant vaccine (IDRI)LEISH-F3

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccineBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsLeishmania donovani infection

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesIndia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesAccess to Advanced Health Institute

China Registration ClassN/A

Develop Information

Active CompaniesAccess to Advanced Health Institute Zydus Cadila

Inactive CompaniesN/A

Active IndicationsLeishmania donovani infection

Inactive IndicationsN/A

Other Information

ATC CodeN/A